Insider Cluster (2 insiders) ·Filed Jul 6, 2026

NUVL

Nuvalent, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $2.1M total
Actionable Insight • Neutral

This cluster is routine and non-informative. The $2.09M in sales is immaterial relative to Nuvalent's $9.8B market cap, and both executives exercised options simultaneously, consistent with pre-planned diversification. No bearish signal. Monitor next clinical data readout or regulatory catalyst for the underlying pipeline.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
NUVL ▲ +0.15% at T+5d
NEUTRAL call ✓ call won +0.15% · α vs SPY -0.34% · entry $123.72 → $123.90
Next anchor: T+20d due 2mo ago
Latest observation: T+11 -1.85% FF3 residual α
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
+0.04%
call +0.04% · α +0.52%
$123.77
settled 3mo ago
T+5d
+0.15%
call +0.15% · α -0.34%
$123.90
settled 3mo ago
T+20d
—
call — · α —
—
due 2mo ago
T+60d
—
call — · α —
—
due 4d ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Nuvalent (CFO and CDO) sold a combined $2.09M in open-market shares this week, all on the same day after exercising stock options. While the cluster involves top officers, the $2.09M represents only ~0.02% of the $9.8B market cap — a trivial, routine proportion consistent with planned option exercises and tax diversification. The insider cluster does not signal material non-public information.

Key Financial Metrics

Direction
selling
Total Value
$2.1M
Insiders
2

Key Facts

  • CFO Alexandra Balcom sold 11,430 shares at $123.58 for $1.41M on July 1, 2026.
  • CDO Darlene Noci sold 5,500 shares at $123.51 for $679K on June 29, 2026, and an additional 23,000 shares at $123.59 for $2.84M on July 1, 2026.
  • All sales followed same-day exercise of stock options at de minimis exercise prices ($0–$18.93), indicating routine cashless exercises and share sales for tax purposes.
  • Total open-market sales by the cluster: ~$2.09M (aggregate unique sales after isolating derivative exercises). This equals ~0.02% of Nuvalent's $9.8B market cap.
  • Both executives exercised options concurrently with their sales, consistent with pre-arranged or vesting-driven plans.

Financial Impact

Total insider open-market sales of ~$2.09M, representing 0.02% of market cap — trivial absolute and relative size.

insider ownership dilution (negligible)

Risk Factors

  • Continued insider selling at a higher clip in coming weeks could signal a change in sentiment — watch for additional Form 4 filings.
  • Nuvalent is a pre-commercialization biotech; fundamental risk remains tied to pipeline execution, not insider trading patterns.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NUVL-1783409687997
18 reports for NUVL
Performance horizon
38% Hit rate 3 of 8 directional calls best @ T+60▲ +21.01%Apr 7, 2026
Filters
Rows
Reports for NUVL — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
15-12G
NEUTRAL ★ 3/10
—awaiting T+5——
Jul 15, 2026
11w ago
25-NSE
NEUTRAL ★ 3/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 15, 2026
11w ago
8-K
BULLISH ★ 5/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.80 $123.96▲ +0.13%▼ −0.73%—
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.72 $123.90▲ +0.15%▼ −0.34%—
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$123.25 $123.43▲ +0.15%▼ −0.53%—
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.45 $123.36▼ −0.07%▼ −0.51%—
Jun 9, 2026
16w ago
8-K
BULLISH ★ 8/10
$123.25 $123.35▲ +0.08%▼ −2.33%—
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$102.40 $105.22▲ +2.75%▲ +1.25%—
Apr 29, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$99.10 $101.47▲ +2.39%▼ −0.72%—
Showing 10 of 18

US Market Status

Market Open — Closes in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 7, 2026